Targeted Forceps Biopsy for Colorectal Tumors

Colorectal Neoplasms Clinical Trial

Official title:

Concordance Rate of Pathology Between Targeted Forceps Biopsy and Resected Specimen for Large Colorectal Tumors

Clinical Trial Details — Status: Recruiting

Administrative data

• NCT number: NCT03604237
• Other study ID #: KNUH201804
• Status: Recruiting
• Phase: N/A
• Start date: September 1, 2017
• Est. completion date: October 1, 2018

Study information

• Verified date: July 2018
• Source: Kyungpook National University
• Contact: n/a
• Is FDA regulated: No
• Study type: Interventional

Clinical Trial Summary

This study evaluates whether targeted forceps biopsy with careful tumor surface evaluation can improve diagnostic accuracy of colorectal tumors larger than 2 cm during colonoscopy.

Recruitment information / eligibility

• Status: Recruiting
• Enrollment: 64
• Est. completion date: October 1, 2018
• Est. primary completion date: August 1, 2018
• Accepts healthy volunteers: No
• Gender: All
• Age group: 19 Years to 85 Years

Eligibility

Inclusion Criteria:

• Patients with colorectal neoplasms of the size larger than 2 cm

Exclusion Criteria:

• Patients who deny the participation in the study

Related Conditions & MeSH terms

• Colorectal Neoplasms

Intervention

Diagnostic Test:
• Targeted group
Forceps biopsy is taken after surface evaluation of the large colorectal tumors.

Locations

Country	Name	City	State
Korea, Republic of	Kyungpook National University Hospital	Daegu

Sponsors (1)

Lead Sponsor	Collaborator
Kyungpook National University

Country where clinical trial is conducted

Korea, Republic of, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	pathologic diagnosis	The pathologic diagnosis of forceps biopsy is compared with the pathologic diagnosis of resected specimen of the colorectal tumor.	7 days